Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
Thelma’s Kitchen cooks up pay-what-you-can cafe concept to preserve community
Twenty people once filled the kitchen of Thelma Gardner’s apartment in search of their next meal. Their hunger for food fueled her hunger for humanity, recounted Father Justin Mathews as he sat sipping coffee in the newly opened Thelma’s Kitchen. The pay-what-you-can restaurant — located inside of the Reconciliation Services building at 3101 Troost Ave.…
Operation Breakthrough bridge over Troost symbolizes ‘real community’ at an intersection
With reflection in his voice, Alvin Brooks paused. “The city has to be a partner,” the Civil Rights activist and veteran Kansas City Police Commissioner said as he spoke of the redevelopment of Troost Avenue — the well known racial dividing line, that has long isolated the east side of the Kansas City metro from the…
Troostapalooza aims to shed the old skin of city’s racial dividing line, says Kemet Coleman
Troostapalooza will build community while constructively addressing the elephant in the room, said Kemet Coleman, organizer of the newly developed street festival. “We wanted to create a home away from home on Troost that is inclusive and sensitive to the historic and existing nuances,” he said. “Not the violent, divisive one that is portrayed by…
Defiant anti-gentrification voice: Clock is ticking on east side neighborhoods, Movement KC
Daniel Edwards isn’t shy about his frustrations with the perception of Kansas City’s east side. “I remember my first corporate lunch after graduating college: the joke was, ‘Nobody wants to go near 35th and Prospect at night time,’” said Edwards, a Kansas City area developer and the founder of Movement KC. “I was like, ‘Yo, it’s…